Brimonidine
Back to searchMolecule Structure
Scientific Name
Brimonidine
Description of the Drug
Brimonidine is an alpha-2 adrenergic agonist used to treat glaucoma and ocular hypertension, as well as facial erythema in rosacea.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00484
http://www.drugbank.ca/drugs/DB00484
Brand Name(s)
Not Available
Company Owner(s)
Apotex Inc, Somerset Therapeutics Llc, Galderma Laboratories Lp, Sandoz Inc, Allergan, Bausch And Lomb Pharmaceuticals Inc, Alcon Laboratories Inc, Teva Parenteral Medicines Inc, Bausch And Lomb Inc, Padagis Israel Pharmaceuticals Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Adrenergic receptor alpha-2 | PROTEIN FAMILY | AGONIST | CHEMBL2095158 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL24670 | ||||
| PharmGKB | PA448665 | ||||
| Human Metabolome Database | HMDB0014627 | ||||
| DrugBank | DB00484 | ||||
| PubChem: Thomson Pharma | 14922559 | 14751364 | |||
| PubChem | 2435 | ||||
| Mcule | MCULE-4542695850 | ||||
| LINCS | LSM-3526 | ||||
| Nikkaji | J23.694B | ||||
| PDBe | J59 | ||||
| BindingDB | 34572 | ||||
| EPA CompTox Dashboard | DTXSID3045221 | ||||
| DrugCentral | 395 | ||||
| Brenda | 105613 | 215760 | |||
| ChemicalBook | CB9111370 | ||||
| Guide to Pharmacology | 5386 | 520 | |||
| rxnorm | BRIMONIDINE | BRIMONIDINE TARTRATE | LUMIFY | MIRVASO | ALPHAGAN |
| KEGG Ligand | C07886 | ||||
| ChEBI | 3175 | ||||
| ZINC | ZINC000021303210 |
